LFTD Partners Inc. (LIFD) stock

LIFDOTCPharmaceutical PreparationsFiscal year ends December 31

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30

$0.10+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

LFTD Partners total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

LFTD Partners's total debt was $3.08M at Jun 30, 2024. For fiscal 2023 it was $3.35M, up 597.0% from the year before.

Period	Period end	Value	Change
FY2023	Dec 31, 2023	$3.35M	+597.0%
FY2012	Dec 31, 2012	$480.48K	+4.6%
FY2011	Dec 31, 2011	$459.45K	–

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q2 FY2024	Jun 30, 2024	$3.08M	–
Q4 FY2023	Dec 31, 2023	$3.35M	–

Parsed from the XBRL in LFTD Partners's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is LIFD.

Gross margin23.5% · median 56.7%

Operating margin-9.0% · median -9.3%

Net margin-77.7% · median -11.3%

Advertisement
300 × 250

See a number that looks wrong?